investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of MHC Class II Association with Plasma Membrane Microdomains
Paul Roche
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Satoshi Ishido
RIKEN
Wako, Japan
Paul Roche
National Cancer Institute (NIH)
Rockville, United States
Related projects
Yang Shi
Histone demethylases and regulation of chromatin and transcription in eukaryotes
All cancers but non-melanoma skin cancer
Alan Perantoni
Growth/Differentiation Factors in Organogenesis
All cancers but non-melanoma skin cancer
Titia De Lange
The role of telomere-related tetraploidization in cancer
All cancers but non-melanoma skin cancer
Douglas R Green
RIPK-Dependent Necrosis in Development and Cancer
All cancers but non-melanoma skin cancer
Giovanna Tosato
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
All cancers but non-melanoma skin cancer
Hematology and hematologic malignancies
Steven C Pruitt
Replication Licensing in Genome Stability, Cancer and Aging
All cancers but non-melanoma skin cancer
Peter S. Nelson
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses
All cancers but non-melanoma skin cancer
Steven Mark Larson
MSKCC Center for Molecular Imaging in Cancer
All cancers but non-melanoma skin cancer
Dennis Klinman
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
All cancers but non-melanoma skin cancer